Telemedicine During COVID 19 - A Useful Tool in COPD Patient Management

1. J. Matusitz, G.-M. Breen, Telemedicine: its effects on health communication, Health Commun. 21 (2007) 73–83, http://dx.doi.org/10.1080/10410230701283439.10.1080/10410230701283439Search in Google Scholar

2. R.L. Bashshur, G.W. Shannon, B.R. Smith, D.C. Alverson, N. Antoniotti,W.G. Barsan, N. Bashshur, E.M. Brown, M.J. Coye, C.R. Doarn, S. Ferguson, J. Grigsby, E.A. Krupinski, J.C. Kvedar, J. Linkous, R.C. Merrell, T. Nesbitt, R. Poropatich, K.S. Rheuban, J.H. Sanders, A.R. Watson, R.S. Weinstein, P. Yellowlees, The empirical foundations of telemedicine interventions for chronic disease management, Telemed. J. E-Health Off. J. Am. Telemed. Assoc. 20 (2014),769–800, http://dx.doi.org/10.1089/tmj.2014.998110.1089/tmj.2014.9981Search in Google Scholar

3. Ambrosino N, Vagheggini G, Mazzoleni S,Vitacca M. -Telemedicine in chronic obstructive pulmonary disease. Breathe 2016; 12: 350–35610.1183/20734735.014616Search in Google Scholar

4. Mihăl an Fl, Coşei V., Borcea C., Ancuţa CTelemedicine in chronic obstructive pulmonary disease: a possible transition to the patient independence-Pneumologia (in press) -2020-0006 69 2020 1-510.2478/pneum-2020-0006Search in Google Scholar

5. Ancochea J, García-Río F, Vázquez-Espinosa E, HernandoSanz A, López-Yepes L, Galera-Martínez R, et al. Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial. European Respiratory Journal. 2018;51(5): pii:1800354.10.1183/13993003.00354-2018Search in Google Scholar

6. Segrelles Calvo G, Gómez-Suárez C, Soriano JB, Zamora E, Gónzalez-Gamarra A, González-Béjar M, et al. A home telehealth program for patients with severe COPD: the PROMETE study. Respiratory Medicine. 2014;108(3): 453–46210.1016/j.rmed.2013.12.003Search in Google Scholar

7. Lenferink A, Brusse-Keizer M, van der Valk PD, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 8: CD011682.10.1002/14651858.CD011682.pub2Search in Google Scholar

8. Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 2015; 147: 894–942.10.1378/chest.14-1676Search in Google Scholar

9. Bourbeau J, Farias R. Making sense of telemedicine in the management of COPD. Eur. Respir J 2018; 51: 1800851 [https://doi.org/10.1183/13993003.00851-2018].10.1183/13993003.00851-2018Search in Google Scholar

10. Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis [published online ahead of print, 2020 Apr 15]. J Med Virol. 2020;10.1002/jmv.25889. doi:10.1002/jmv.2588910.1002/jmv.25889Search in Google Scholar

11. Nussbaumer-Streit_B, Mayr_V, Dobrescu_AI, Chapman_A, Persad_E, Klerings_I, Wagner_G, Siebert_U, Christof_C, Zachariah_C, Gartlehner_G.-Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No.: CD013574. DOI: 10.1002/14651858.CD013574.10.1002/14651858.CD013574Search in Google Scholar